USD
GBP 
CNY 
EUR 
INR 
JPY 
MYR 
ZAR 
KRW 
THB 
Future Growth Potential Enhanced by the Pandemic and Growth Opportunities in Chronic Disease Management
06-Oct-2021
North America
Market Research
PBD9-01-00-00-00
HC03453-NA-MT_25801
The prevalence of chronic diseases has continued to rise, and the expenses of managing them or treating the complications arising from poor management cost the US healthcare system hundreds of billions of dollars each year. Clearly, physicians alone cannot control this rising challenge, and to ensure behavioral change, several tools and approaches are necessary to support the care team, such as remote patient monitoring (RPM), digital therapeutics, and the right nudges for motivation at the right time.
Several market participants are now offering such solutions to providers, payers, and employers (and in some cases, directly to the patients) to help patients suffering from cardiovascular, diabetes, and chronic obstructive pulmonary disorder (COPD) manage their conditions better.
The market participants are categorized on the basis of the kind of solutions they offer—RPM and digital therapeutics solutions, on the tech-only solution side, and valued-added RPM, coaching platforms and digital care, on the ‘tech + human’ intervention solutions side. While the industry continues to debate the better approach, the segments will see significant growth, as all of these approaches are gunning to help chronically ill patients stay healthier longer, reduce frequency and cost of hospital admissions, or disease-related complications in the long run. These tech-enabled solutions also address one of the major challenges of the healthcare industry—shortage of resources. The solutions complement the services of doctors and healthcare professionals and empower a larger portion of the increasing patient population with tech-enabled tools.
This study covers cardiovascular conditions, diabetes, and COPD, the major diseases afflicting the US population and responsible for a sizeable portion of the $3 trillion US healthcare cost. This study defines, compares, and contrasts the different models of chronic disease management care models, such as RPM, digital therapeutics, coaching platforms, value-added RPM, and digital care in terms of their strengths and weaknesses, revenues and growth rates, and potential to serve various customer segments. It identifies the major participants in each segment and also outlines the current focus of all segments within each of the three disease areas’ patient pathways. Finally, it covers evolving business models, and select profiles of some companies, while also highlighting the future of this market in terms of reimbursements and market growth, ultimately helping uncover the major growth opportunities in this sector.
Key Issues Addressed
- What are the different segments for solution vendors offering chronic disease management solutions, and how do they differ from one another?
- What are the current (and future) target customer segments for each of these vendor segments?
- Which are the unique, leading participants in this sector, and what are the evolving business models in this space?
- How and when does the market adoption shift from just management to broader adoption of management-and-prevention solutions, in the light of current trends?
- How are current pharmaceutical and medtech incumbents viewing the rise of such solutions, and how are they playing a role in this space?
Author: Siddharth Shah
Why Is It Increasingly Difficult to Grow?
The Strategic Imperative 8™
Impact of the Top Three Strategic Imperatives on the Global Chronic Disease Management Industry
Growth Opportunities Fuel the Growth Pipeline Engine™
Top 10 Causes of DALYs and Mortality, 2000–2019
Top 10 Causes of Mortality by GNI Per Capita, 2019
Prevalence of the Top 3 Chronic Conditions
Obesity Driving Incidence of Chronic Conditions Worldwide
Evolution of Approaches to Manage Chronic Condition Patients
Analysis of Prevalent Disease Management Approaches
The ‘Digital Care’ Model for Chronic Disease Management
Impact of the COVID-19 Pandemic on Virtual Care
Chronic Disease Management Snapshot, US
Chronic Disease Management Growth Opportunity Snapshot
Scope of Analysis
Segmentation
Definitions
Key Competitors
Key Growth Metrics
Growth Drivers
Growth Restraints
Forecast Assumptions
Revenue Forecast
Revenue Forecast by Care Model
Revenue Forecast Analysis
Competitive Environment
Revenue Share
Revenue Share Analysis
Key Growth Metrics, RPM
Revenue Forecast, RPM
Forecast Analysis, RPM
Key Growth Metrics, Digital Care Providers
Revenue Forecast, Digital Care Providers
Forecast Analysis, Digital Care Providers
Key Growth Metrics, Coaching Platforms
Revenue Forecast, Coaching Platforms
Forecast Analysis, Coaching Platforms
Key Growth Metrics, Value-added RPM
Revenue Forecast, Value-added RPM
Forecast Analysis, Value-added RPM
Key Growth Metrics, Digital Therapeutics
Revenue Forecast, Digital Therapeutics
Forecast Analysis, Digital Therapeutics
Mapping Vendor Focus Areas Across the Cardiovascular Patient Pathway
Managing Cardiovascular Conditions & Risk Stratification
Unique Cardiovascular Disease Management Market Participants
Future Roadmap
Mapping Vendor Focus Areas Across Diabetes Patient Pathway
Managing Diabetics—Risk Stratification
Unique Diabetes Management Market Participants
Future Roadmap
Mapping Vendor Focus Areas Across COPD Patient Pathway
Managing COPD—Risk Stratification
Unique COPD Management Market Participants
Future Roadmap
Approaches to Maximize Reach and Revenue
RPM Chronic Disease Management Success Story—Validic
End-to-End Integration Approach—Raziel Health
Addressing a Variety of Customer Needs—Marketplaces
Innovative Patient Engagement Models with a Business Model Impact
Growth of Disease Management and Prevention Programs
Timeline for Disease Management Programs’ Adoption
Timeline for Disease Management Programs’ Adoption (continued)
RPM Segment Poised to Benefit the Most from Future Chronic Condition Management Programs
Potential Reach of Chronic Disease Management Participants
Changing Epidemiology & Prevalent Growth Rates
Hospital at Home—The Impetus to Bolster the Reach of Chronic Disease Management Programs
Technology Advancement Simplifying Vitals Gathering to Help Address Compliance Barriers to Chronic Disease Management
Disease Management Growth Opportunities for Incumbent Medtech and Pharma Participants
Growth Opportunity 1—Addressal of Risk Factors, Social Determinants, and Complications Management for Improved Outcomes
Growth Opportunity 1—Addressal of Risk Factors, Social Determinants, and Complications Management for Improved Outcomes (continued)
Growth Opportunity 2—Partnerships with Hospital-at-Home Vendors for Management of Acute Events
Growth Opportunity 2—Partnership with Hospital-at-Home Vendors for Management of Acute Events (continued)
Growth Opportunity 3—Comorbidity Treatments for Holistic Wellbeing
Growth Opportunity 3—Comorbidity Treatments for Holistic Wellbeing (continued)
Growth Opportunity 4—Pharmaceutical/Medtech OEM Partnerships with Disease Management Vendors for Adherence and Data Access
Growth Opportunity 4—Pharmaceutical/Medtech OEM Partnerships with Disease Management Vendors for Adherence and Data Access (continued)
Growth Opportunity 5—New Features and Business Models for Enhanced Revenue Streams
Growth Opportunity 5—New Features and Business Models for Enhanced Revenue Streams (continued)
Growth Opportunity 5—New Features and Business Models for Enhanced Revenue Streams (continued)
Your Next Steps
Why Frost, Why Now?
List of Exhibits
List of Exhibits (continued)
List of Exhibits (continued)
Legal Disclaimer
Speak directly with our analytics experts for tailored recommendations.
Recent related Healthcare research
18 Sep 2026 | Global | Frost Radar
Frost Radar™: Life Sciences Laboratory Information Management Systems, 2026
Laboratory information management systems (LIMS) have been used in life sciences since laboratories began digitizing sample tracking and data management in the 1970s. Modern LIMS solutions enhance efficiency by automating workflows, improving data accuracy, and enabling seamless integration and offe...
18 Sep 2026 | Global | Technology Research
Innovations and Growth Opportunities in AI-Enabled Discovery and Diagnostics, Precision Therapeutics, and Next-Generation Vaccine Platforms
This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) provides a comprehensive overview of breakthrough innovations transforming AI-enabled discovery, precision diagnostics, cell engineering, targeted therapeutics, vaccines, and skin health across oncology, metaboli...
15 Sep 2026 | Global | Market Research
Vendor Profiles: Advanced Wound Care Management Market, Global, 2025
The wound care market is being transformed by advanced technologies and evolving care models that focus on improving patient outcomes and reducing healthcare costs. Innovations such as smart sensor-embedded dressings, artificial intelligence (AI)-based wound imaging systems, enhanced negative pressu...
11 Sep 2026 | Global | Frost Radar
Frost Radar™: Pharmaceutical Commercialization Solutions and Services, 2026
Pharmaceutical commercialization is a multidimensional concept in the successful launch and distribution of a drug. The process includes the development of a pricing strategy that reflects the drug’s value, negotiation with payers to ensure drug cost coverage, regulatory compliance, and the generati...
07 Sep 2026 | Global | Technology Research
Synthetic Antibodies and AI-Optimized Immunotherapies
Artificial intelligence is becoming increasingly relevant to antibody discovery and immunotherapy development, supporting target identification, de novo antibody design, antibody engineering, clinical intelligence, and bioprocessing. Advances in generative AI, protein language models, diffusion mode...
Purchase includes:
- Report download
- Growth Dialog™ with our experts
Growth Dialog™
A tailored session with you where we identify the:- Strategic Imperatives
- Growth Opportunities
- Best Practices
- Companies to Action
Impacting your company's future growth potential.
Key Issues Addressed
- What are the different segments for solution vendors offering chronic disease management solutions, and how do they differ from one another
- What are the current (and future) target customer segments for each of these vendor segments
- Which are the unique, leading participants in this sector, and what are the evolving business models in this space
- How and when does the market adoption shift from just management to broader adoption of management-and-prevention solutions, in the light of current trends
- How are current pharmaceutical and medtech incumbents viewing the rise of such solutions, and how are they playing a role in this space
Author: Siddharth Shah
| Deliverable Type | Market Research |
|---|---|
| No Index | No |
| Podcast | No |
| Author | Siddharth Shah |
| Industries | Healthcare |
| WIP Number | PBD9-01-00-00-00 |
| Is Prebook | No |
| GPS Codes | 9564-B1,9600-B1,9612-B1,9A47-B1,9A4B-B1 |
US Chronic Disease Management Growth Opportunities
$4,950.00
Special Price $3,712.50 save 25 %